...
首页> 外文期刊>Therapeutics and Clinical Risk Management >Randomized controlled study of the antipyretic efficacy of oral paracetamol, intravenous paracetamol, and intramuscular diclofenac in patients presenting with fever to the emergency department
【24h】

Randomized controlled study of the antipyretic efficacy of oral paracetamol, intravenous paracetamol, and intramuscular diclofenac in patients presenting with fever to the emergency department

机译:口服扑热息痛,静脉内扑热息痛和肌内双氯芬酸对急诊科发烧患者的解热效果的随机对照研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Fever is a common problem in adults visiting the emergency department. Extensive studies have been done in children comparing the efficacy of various antipyretics. However, studies on the efficacy of antipyretic drugs in adults are very scarce. To the best of our knowledge, no controlled trial has been carried out comparing the antipyretic efficacy of paracetamol (oral and intravenous) and intramuscular diclofenac in adults. Methods: In this parallel-group, open-label trial, participants aged 14–75 years presenting with fever who had a temperature of more than 38.5°C were enrolled and treated. Participants were randomly allocated to receive treatment with 1,000 mg oral paracetamol (n = 145), 1,000 mg intravenous paracetamol (n = 139), or 75 mg intramuscular diclofenac (n = 150). The primary outcome was degree of reduction in mean oral temperature at 90 minutes. The efficacy of diclofenac versus oral and intravenous paracetamol was assessed by superiority comparison. Analysis was done using intention to treat principles. Results: After 90 minutes, all three groups showed a significant reduction in mean temperature, with intramuscular diclofenac showing the greatest reduction (?1.44 ± 0.43, 95% confidence interval [CI] ?1.4 to ?2.5) and oral paracetamol the least (?1.08 ± 0.51, 95% CI ?0.99 to ?2.2). After 120 minutes, there was a significant difference observed in the mean change from baseline temperature between the three treatment groups ( P < 0.0001). Significant changes in temperature were observed in favor of intramuscular diclofenac over oral and intravenous paracetamol at each time point from 60 minutes through 120 minutes inclusive. Conclusion: Both intramuscular diclofenac and intravenous paracetamol showed superior antipyretic activity than oral paracetamol. However, in view of its ease of administration, intramuscular diclofenac can be used as a first-choice antipyretic in febrile adults in the emergency department.
机译:背景:发烧是成人前往急诊科的常见问题。在儿童中进行了广泛的研究,比较了各种解热药的疗效。然而,关于解热药在成人中的功效的研究非常少。据我们所知,尚未进行对乙酰氨基酚(口服和静脉内)和肌内双氯芬酸对成人的解热效果比较的对照试验。方法:在这项平行组,开放标签试验中,招募并治疗了14-75岁,发烧且温度超过38.5°C的参与者。参与者被随机分配接受1,000 mg口服对乙酰氨基酚(n = 145),1,000 mg静脉对乙酰氨基酚(n = 139)或75 mg肌内双氯芬酸(n = 150)进行治疗。主要结果是90分钟时平均口腔温度降低的程度。通过优势比较评估双氯芬酸相对于口服和静脉对乙酰氨基酚的疗效。使用意向性原则进行分析。结果:90分钟后,所有三个组的平均温度均显着降低,肌肉内双氯芬酸的降低幅度最大(?1.44±0.43,95%置信区间[CI]范围从1.4至2.5),而口服对乙酰氨基酚的降幅最小(? 1.08±0.51,95%CI≤0.99至≤2.2)。 120分钟后,三个治疗组之间的基线温度平均值变化存在显着差异(P <0.0001)。在每个时间点(从60分钟到120分钟),包括口服和静脉注射对乙酰氨基酚时,观察到温度变化明显,有利于肌注双氯芬酸。结论:肌内双氯芬酸和静脉对乙酰氨基酚均显示出比口服对乙酰氨基酚更好的解热活性。但是,鉴于其易用性,肌内双氯芬酸可以在急诊科的发热成人中用作首选的退烧药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号